The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
GERD-Global Market Insights and Sales Trends 2024
Synopsis
Gastroesophageal reflux disease involves the backflow of stomach’s content to mouth through esophagus which gives a burning sensation behind breast bone. Gastroesophageal reflux disease is a common digestive disorder which affects the food pipe and lower esophageal sphincter by deteriorating its elasticity. Gastroesophageal reflux disease occurs due to lifestyle changes and irregular eating habits & over consumption of fatty foods, coffee, alcoholic beverages, citrus fruits and pepper. In Gastroesophageal reflux disease there is excessive production of acid which damages the stomach lining and ultimately cause ulcers. Gastroesophageal reflux disease includes other symptoms such as regurgitation and dysphagia. However, abnormal reflux may cause uncharacteristic symptoms such as coughing, sore throat, otitis media, chest pain and enamel erosion or other dental manifestations.
The global GERD market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of GERD in various end use industries. The expanding demands from the Hospital Pharmacy, Drug Stores, General Stores and Supermarkets, are propelling GERD market. Proton Pumps Inhibitors, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the H2 Receptor Antagonists segment is estimated at % CAGR for the next seven-year period.
The overall market has been experiencing a downturn in terms of revenue in the past several years as the leading drugs for GERD treatment have lost their patent protection, with their market shares now largely consumed by over-the-counter (OTC) and generic medications. Although loss of exclusivity of high-grossing drugs have caused a market fall-off, the demand for acid reducing drugs due to the high prevalence and incidence levels of GERD will prove beneficial to the industry from a commercial standpoint. GERD is one of the commonly observed recurrent gastrointestinal disorders worldwide. The prevalence of acid reflux and related symptoms has increased across the globe by nearly 50% over the last decade. This disorder not only has major effects on the health and quality of patient lives, but also extends to the healthcare system and economy.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for GERD, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global GERD market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global GERD market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, GERD sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of GERD covered in this report include AstraZeneca, Eisai, GlaxoSmithKline, Johnson & Johnson and Takeda, etc.
The global GERD market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AstraZeneca
Eisai
GlaxoSmithKline
Johnson & Johnson
Takeda
Global GERD market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global GERD market, Segment by Type:
Proton Pumps Inhibitors
H2 Receptor Antagonists
Antacids
Prokinetics
CAM
Global GERD market, by Application
Hospital Pharmacy
Drug Stores
General Stores
Supermarkets
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of GERD manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of GERD in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Gastroesophageal reflux disease involves the backflow of stomach’s content to mouth through esophagus which gives a burning sensation behind breast bone. Gastroesophageal reflux disease is a common digestive disorder which affects the food pipe and lower esophageal sphincter by deteriorating its elasticity. Gastroesophageal reflux disease occurs due to lifestyle changes and irregular eating habits & over consumption of fatty foods, coffee, alcoholic beverages, citrus fruits and pepper. In Gastroesophageal reflux disease there is excessive production of acid which damages the stomach lining and ultimately cause ulcers. Gastroesophageal reflux disease includes other symptoms such as regurgitation and dysphagia. However, abnormal reflux may cause uncharacteristic symptoms such as coughing, sore throat, otitis media, chest pain and enamel erosion or other dental manifestations.
The global GERD market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of GERD in various end use industries. The expanding demands from the Hospital Pharmacy, Drug Stores, General Stores and Supermarkets, are propelling GERD market. Proton Pumps Inhibitors, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the H2 Receptor Antagonists segment is estimated at % CAGR for the next seven-year period.
The overall market has been experiencing a downturn in terms of revenue in the past several years as the leading drugs for GERD treatment have lost their patent protection, with their market shares now largely consumed by over-the-counter (OTC) and generic medications. Although loss of exclusivity of high-grossing drugs have caused a market fall-off, the demand for acid reducing drugs due to the high prevalence and incidence levels of GERD will prove beneficial to the industry from a commercial standpoint. GERD is one of the commonly observed recurrent gastrointestinal disorders worldwide. The prevalence of acid reflux and related symptoms has increased across the globe by nearly 50% over the last decade. This disorder not only has major effects on the health and quality of patient lives, but also extends to the healthcare system and economy.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for GERD, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global GERD market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global GERD market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, GERD sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of GERD covered in this report include AstraZeneca, Eisai, GlaxoSmithKline, Johnson & Johnson and Takeda, etc.
The global GERD market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AstraZeneca
Eisai
GlaxoSmithKline
Johnson & Johnson
Takeda
Global GERD market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global GERD market, Segment by Type:
Proton Pumps Inhibitors
H2 Receptor Antagonists
Antacids
Prokinetics
CAM
Global GERD market, by Application
Hospital Pharmacy
Drug Stores
General Stores
Supermarkets
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of GERD manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of GERD in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 GERD Market Overview
1.1 GERD Product Overview
1.2 GERD Market Segment by Type
1.2.1 Proton Pumps Inhibitors
1.2.2 H2 Receptor Antagonists
1.2.3 Antacids
1.2.4 Prokinetics
1.2.5 CAM
1.3 Global GERD Market Size by Type
1.3.1 Global GERD Market Size Overview by Type (2018-2029)
1.3.2 Global GERD Historic Market Size Review by Type (2018-2023)
1.3.3 Global GERD Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America GERD Sales Breakdown by Type (2018-2023)
1.4.2 Europe GERD Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific GERD Sales Breakdown by Type (2018-2023)
1.4.4 Latin America GERD Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa GERD Sales Breakdown by Type (2018-2023)
2 Global GERD Market Competition by Company
2.1 Global Top Players by GERD Sales (2018-2023)
2.2 Global Top Players by GERD Revenue (2018-2023)
2.3 Global Top Players by GERD Price (2018-2023)
2.4 Global Top Manufacturers GERD Manufacturing Base Distribution, Sales Area, Product Type
2.5 GERD Market Competitive Situation and Trends
2.5.1 GERD Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by GERD Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in GERD as of 2022)
2.7 Date of Key Manufacturers Enter into GERD Market
2.8 Key Manufacturers GERD Product Offered
2.9 Mergers & Acquisitions, Expansion
3 GERD Status and Outlook by Region
3.1 Global GERD Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global GERD Historic Market Size by Region
3.2.1 Global GERD Sales in Volume by Region (2018-2023)
3.2.2 Global GERD Sales in Value by Region (2018-2023)
3.2.3 Global GERD Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global GERD Forecasted Market Size by Region
3.3.1 Global GERD Sales in Volume by Region (2024-2029)
3.3.2 Global GERD Sales in Value by Region (2024-2029)
3.3.3 Global GERD Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global GERD by Application
4.1 GERD Market Segment by Application
4.1.1 Hospital Pharmacy
4.1.2 Drug Stores
4.1.3 General Stores
4.1.4 Supermarkets
4.2 Global GERD Market Size by Application
4.2.1 Global GERD Market Size Overview by Application (2018-2029)
4.2.2 Global GERD Historic Market Size Review by Application (2018-2023)
4.2.3 Global GERD Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America GERD Sales Breakdown by Application (2018-2023)
4.3.2 Europe GERD Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific GERD Sales Breakdown by Application (2018-2023)
4.3.4 Latin America GERD Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa GERD Sales Breakdown by Application (2018-2023)
5 North America GERD by Country
5.1 North America GERD Historic Market Size by Country
5.1.1 North America GERD Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America GERD Sales in Volume by Country (2018-2023)
5.1.3 North America GERD Sales in Value by Country (2018-2023)
5.2 North America GERD Forecasted Market Size by Country
5.2.1 North America GERD Sales in Volume by Country (2024-2029)
5.2.2 North America GERD Sales in Value by Country (2024-2029)
6 Europe GERD by Country
6.1 Europe GERD Historic Market Size by Country
6.1.1 Europe GERD Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe GERD Sales in Volume by Country (2018-2023)
6.1.3 Europe GERD Sales in Value by Country (2018-2023)
6.2 Europe GERD Forecasted Market Size by Country
6.2.1 Europe GERD Sales in Volume by Country (2024-2029)
6.2.2 Europe GERD Sales in Value by Country (2024-2029)
7 Asia-Pacific GERD by Region
7.1 Asia-Pacific GERD Historic Market Size by Region
7.1.1 Asia-Pacific GERD Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific GERD Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific GERD Sales in Value by Region (2018-2023)
7.2 Asia-Pacific GERD Forecasted Market Size by Region
7.2.1 Asia-Pacific GERD Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific GERD Sales in Value by Region (2024-2029)
8 Latin America GERD by Country
8.1 Latin America GERD Historic Market Size by Country
8.1.1 Latin America GERD Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America GERD Sales in Volume by Country (2018-2023)
8.1.3 Latin America GERD Sales in Value by Country (2018-2023)
8.2 Latin America GERD Forecasted Market Size by Country
8.2.1 Latin America GERD Sales in Volume by Country (2024-2029)
8.2.2 Latin America GERD Sales in Value by Country (2024-2029)
9 Middle East and Africa GERD by Country
9.1 Middle East and Africa GERD Historic Market Size by Country
9.1.1 Middle East and Africa GERD Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa GERD Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa GERD Sales in Value by Country (2018-2023)
9.2 Middle East and Africa GERD Forecasted Market Size by Country
9.2.1 Middle East and Africa GERD Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa GERD Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 AstraZeneca
10.1.1 AstraZeneca Company Information
10.1.2 AstraZeneca Introduction and Business Overview
10.1.3 AstraZeneca GERD Sales, Revenue and Gross Margin (2018-2023)
10.1.4 AstraZeneca GERD Products Offered
10.1.5 AstraZeneca Recent Development
10.2 Eisai
10.2.1 Eisai Company Information
10.2.2 Eisai Introduction and Business Overview
10.2.3 Eisai GERD Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Eisai GERD Products Offered
10.2.5 Eisai Recent Development
10.3 GlaxoSmithKline
10.3.1 GlaxoSmithKline Company Information
10.3.2 GlaxoSmithKline Introduction and Business Overview
10.3.3 GlaxoSmithKline GERD Sales, Revenue and Gross Margin (2018-2023)
10.3.4 GlaxoSmithKline GERD Products Offered
10.3.5 GlaxoSmithKline Recent Development
10.4 Johnson & Johnson
10.4.1 Johnson & Johnson Company Information
10.4.2 Johnson & Johnson Introduction and Business Overview
10.4.3 Johnson & Johnson GERD Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Johnson & Johnson GERD Products Offered
10.4.5 Johnson & Johnson Recent Development
10.5 Takeda
10.5.1 Takeda Company Information
10.5.2 Takeda Introduction and Business Overview
10.5.3 Takeda GERD Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Takeda GERD Products Offered
10.5.5 Takeda Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 GERD Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 GERD Industrial Chain Analysis
11.4 GERD Market Dynamics
11.4.1 GERD Industry Trends
11.4.2 GERD Market Drivers
11.4.3 GERD Market Challenges
11.4.4 GERD Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 GERD Distributors
12.3 GERD Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
